Literature DB >> 25297924

Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.

Martijn T Wijburg1, Bob W van Oosten, Jean-Luc Murk, Ouafae Karimi, Joep Killestein, Mike P Wattjes.   

Abstract

Granule cell neuronopathy (GCN) is a rare JC virus (JCV)-related disease in immunocompromised patients, characterized by lytic infection of the cerebellar granule cell layer. To enable early diagnosis and intervention, we identify features of GCN and describe possible aspects of disease heterogeneity. We report on two new cases of GCN in HIV-infected patients of whom we retrospectively assessed clinical and radiologic data. In addition, we carried out a literature search and review of clinical, radiologic and histopathologic findings of all published GCN cases. Including the two new cases reported here, a total of 18 GCN cases were included in this study. HIV infection, present in 12 of the cases, was the most common underlying condition, followed by monoclonal antibody treatment which was present in three cases. Cerebellar atrophy was detected in all except two cases. In 12 patients a heterogeneous distribution pattern of white matter changes in the cerebellum and brainstem was observed. Imaging findings in GCN are remarkably heterogeneous; exhibiting cerebellar atrophy, as well as white matter pathology, particularly in the adjacent infratentorial white matter. This suggests an overlap of GCN with other JCV-related diseases, such as progressive multifocal leukoencephalopathy.

Entities:  

Mesh:

Year:  2014        PMID: 25297924     DOI: 10.1007/s00415-014-7530-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  42 in total

1.  Possible JCV granular cell neuronopathy in a patient with HIV infection.

Authors:  Ik Lin Tan; Bruce J Brew
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

2.  PML in a patient treated with dimethyl fumarate from a compounding pharmacy.

Authors:  Bob W van Oosten; Joep Killestein; Frederik Barkhof; Chris H Polman; Mike P Wattjes
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

3.  Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis.

Authors:  Muriel Stoppe; Eva Thomä; Uwe Gerd Liebert; Eugene O Major; Karl-Titus Hoffmann; Joseph Claßen; Florian Then Bergh
Journal:  J Neurol       Date:  2014-03-18       Impact factor: 4.849

Review 4.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

5.  JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: clinical presentations, associated factors with mortality and outcome.

Authors:  Felipe Piza; Maria Cristina Fink; Gilberto S Nogueira; Claudio S Pannuti; Augusto C Penalva de Oliveira; José Ernesto Vidal
Journal:  Braz J Infect Dis       Date:  2012 Mar-Apr       Impact factor: 1.949

6.  JC virus granule cell neuronopathy in a child with CD40 ligand deficiency.

Authors:  Jonathan H Hecht; Orit A Glenn; Diane W Wara; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2007-03       Impact factor: 3.372

Review 7.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Authors:  Hirohisa Watanabe; Yufuko Saito; Shinichi Terao; Tetsuo Ando; Teruhiko Kachi; Eiichiro Mukai; Ikuko Aiba; Yuji Abe; Akiko Tamakoshi; Manabu Doyu; Masaaki Hirayama; Gen Sobue
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

Review 8.  The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Mike P Wattjes; Nancy D Richert; Joep Killestein; Marlieke de Vos; Esther Sanchez; Petur Snaebjornsson; Diego Cadavid; Frederik Barkhof
Journal:  Mult Scler       Date:  2013-11-05       Impact factor: 6.312

9.  Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.

Authors:  Boleslaw Lach; Barbara Connolly; Christian Wüthrich; Igor J Koralnik
Journal:  Neuropathology       Date:  2013-05-20       Impact factor: 1.906

Review 10.  Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

View more
  16 in total

1.  Granule Cell Neuronopathy in a Patient with Common Variable Immunodeficiency.

Authors:  Andrew McLean-Tooke; Constantine Chris Phatouros; Glenys Chidlow; David W Smith; Peter Silbert
Journal:  J Clin Immunol       Date:  2019-04-16       Impact factor: 8.317

Review 2.  Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases.

Authors:  Robbert-Jan Gieselbach; Annemarie H Muller-Hansma; Martijn T Wijburg; Marjolein S de Bruin-Weller; Bob W van Oosten; Dennis J Nieuwkamp; Frank E Coenjaerts; Mike P Wattjes; Jean-Luc Murk
Journal:  J Neurol       Date:  2017-05-23       Impact factor: 4.849

3.  Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.

Authors:  Elizabeth C Neil; Lisa M DeAngelis
Journal:  Blood Adv       Date:  2017-10-18

4.  Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.

Authors:  Christian Wüthrich; Stephanie Batson; Igor J Koralnik
Journal:  J Neuropathol Exp Neurol       Date:  2015-08       Impact factor: 3.685

Review 5.  Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area.

Authors:  Dhanashri P Miskin; Igor J Koralnik
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

Review 6.  Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders.

Authors:  Conor Fearon; Sapna Rawal; Diana Olszewska; Paula Alcaide-Leon; Drew S Kern; Soumya Sharma; Shyam K Jaiswal; Jagarlapudi M K Murthy; Ainhi D Ha; Raymond S Schwartz; Victor S C Fung; Chauncey Spears; Tracy Tholanikunnel; Leonardo Almeida; Taku Hatano; Yutaka Oji; Nobutaka Hattori; Shantanu Shubham; Hrishikesh Kumar; Roongroj Bhidayasiri; Christopher Laohathai; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2022-02-03

7.  JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.

Authors:  David N Soleimani-Meigooni; Katherine E Schwetye; Maria Reyes Angeles; Caroline F Ryschkewitsch; Eugene O Major; Xin Dang; Igor J Koralnik; Robert E Schmidt; David B Clifford; F Matthew Kuhlmann; Robert C Bucelli
Journal:  J Neurovirol       Date:  2016-07-15       Impact factor: 2.643

8.  A Case of John Cunningham Virus Induced Rhombencephalitis after Rituximab Therapy for Idiopathic Thrombocytopenic Purpura.

Authors:  Silpita Katragadda; Varshaa Koneru; Genevieve Devany; Aaron S DeWitt; Vasudev H Tati
Journal:  Case Rep Infect Dis       Date:  2021-06-15

9.  Central nervous system disease with JC virus infection in adults with congenital HIV.

Authors:  Caleb R S McEntire; Kathryn T Fong; Dan Tong Jia; Ellen R Cooper; Anna M Cervantes-Arslanian; Farrah J Mateen; Pria Anand; Kiran T Thakur
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

10.  Concomitant granule cell neuronopathy in patients with natalizumab-associated PML.

Authors:  Martijn T Wijburg; Dorine Siepman; Jeroen J J van Eijk; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.